BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oki E, Kakeji Y, Zhao Y, Yoshida R, Ando K, Masuda T, Ohgaki K, Morita M, Maehara Y. Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Ann Surg Oncol. 2009;16:2510-2515. [PMID: 19565284 DOI: 10.1245/s10434-009-0580-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Kleo K, Jovanovic VM, Arndold A, Lehmann A, Lammert H, Berg E, Harloff H, Treese C, Hummel M, Daum S. Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies. J Cancer Res Clin Oncol 2023;149:1049-61. [PMID: 35246724 DOI: 10.1007/s00432-022-03944-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mohamed AA, Gordon A, Cartwright E, Cunningham D. Optimising Multimodality Treatment of Resectable Oesophago-Gastric Adenocarcinoma. Cancers (Basel) 2022;14:586. [PMID: 35158854 DOI: 10.3390/cancers14030586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rastogi A, Bihari C, Patil AG, Majumdar K, Das P. Molecular Classifications of Gastrointestinal Tract Tumors. Surgical Pathology of the Gastrointestinal System 2022. [DOI: 10.1007/978-981-16-6395-6_23] [Reference Citation Analysis]
4 Qadir J, Majid S, Khan MS, Rashid F, Wani MD, Bhat SA. Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer. Pathol Oncol Res 2021;27:1609826. [PMID: 34924820 DOI: 10.3389/pore.2021.1609826] [Reference Citation Analysis]
5 Guan WL, Ma Y, Cui YH, Liu TS, Zhang YQ, Zhou ZW, Xu JY, Yang LQ, Li JY, Sun YT, Xu RH, Wang FH, Qiu MZ. The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter Analysis. Front Oncol 2021;11:712760. [PMID: 34900669 DOI: 10.3389/fonc.2021.712760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Vošmik M, Kopecký J, John S, Kubeček O, Lochman P, Banni AM, Hruška L, Sirák I. Combined Therapy of Locally Advanced Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas: State of the Art and Aspects of Predictive Factors. Cancers (Basel) 2021;13:4591. [PMID: 34572818 DOI: 10.3390/cancers13184591] [Reference Citation Analysis]
7 Nshizirungu JP, Bennis S, Mellouki I, Benajah DA, Lahmidani N, El Bouhaddoutti H, Ibn Majdoub K, Ibrahimi SA, Pires Celeiro S, Viana-Pereira M, Manuel Reis R. Microsatellite Instability Analysis in Gastric Carcinomas of Moroccan Patients. Genet Test Mol Biomarkers 2021;25:116-23. [PMID: 33596142 DOI: 10.1089/gtmb.2020.0146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Hu Q, Nonaka K, Wakiyama H, Miyashita Y, Fujimoto Y, Jogo T, Hokonohara K, Nakanishi R, Hisamatsu Y, Ando K, Kimura Y, Masuda T, Oki E, Mimori K, Oda Y, Mori M. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer. Cancer Med 2021;10:3129-38. [PMID: 33769705 DOI: 10.1002/cam4.3828] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Cai Z, Song H, Fingerhut A, Sun J, Ma J, Zhang L, Li S, Yu C, Zheng M, Zang L. A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer. BMC Cancer 2021;21:319. [PMID: 33765970 DOI: 10.1186/s12885-021-08044-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zepeda-Najar C, Palacios-Astudillo RX, Chávez-Hernández JD, Lino-Silva LS, Salcedo-Hernández RA. Prognostic impact of microsatellite instability in gastric cancer. Contemp Oncol (Pozn) 2021;25:68-71. [PMID: 33911985 DOI: 10.5114/wo.2021.104939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 De Souza ALPB. Finding the hot spot: identifying immune sensitive gastrointestinal tumors. Transl Gastroenterol Hepatol 2020;5:48. [PMID: 33073043 DOI: 10.21037/tgh.2019.12.11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Kim JW, Cho SY, Chae J, Kim JW, Kim TY, Lee KW, Oh DY, Bang YJ, Im SA. Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer. Cancer Res Treat 2020;52:1178-87. [PMID: 32599979 DOI: 10.4143/crt.2020.313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 van Velzen MJM, Derks S, van Grieken NCT, Haj Mohammad N, van Laarhoven HWM. MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma. Cancer Treat Rev 2020;86:102024. [PMID: 32388292 DOI: 10.1016/j.ctrv.2020.102024] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 13.7] [Reference Citation Analysis]
14 Tsai CY, Lin TA, Huang SC, Hsu JT, Yeh CN, Chen TC, Chiu CT, Chen JS, Yeh TS. Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched. Oncologist 2020;25:e1021-30. [PMID: 32058649 DOI: 10.1634/theoncologist.2019-0419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
15 Afshari F, Soleyman-Jahi S, Keshavarz-Fathi M, Roviello G, Rezaei N. The promising role of monoclonal antibodies for gastric cancer treatment. Immunotherapy 2019;11:347-64. [PMID: 30678552 DOI: 10.2217/imt-2018-0093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
16 Zhao X, Dai D, Li X, Shen B, Chen X, Shu Y, Wang D. A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer. Gastric Cancer 2019;22:1121-9. [PMID: 30989434 DOI: 10.1007/s10120-019-00962-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
17 Kim SM, An JY, Byeon SJ, Lee J, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S. Prognostic value of mismatch repair deficiency in patients with advanced gastric cancer, treated by surgery and adjuvant 5-fluorouracil and leucovorin chemoradiotherapy. Eur J Surg Oncol 2020;46:189-94. [PMID: 31500870 DOI: 10.1016/j.ejso.2019.08.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
18 Zhao P, Li L, Jiang X, Li Q. Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy. J Hematol Oncol 2019;12:54. [PMID: 31151482 DOI: 10.1186/s13045-019-0738-1] [Cited by in Crossref: 225] [Cited by in F6Publishing: 247] [Article Influence: 56.3] [Reference Citation Analysis]
19 Martinez-Ciarpaglini C, Fleitas-Kanonnikoff T, Gambardella V, Llorca M, Mongort C, Mengual R, Nieto G, Navarro L, Huerta M, Rosello S, Roda D, Tarazona N, Navarro S, Ribas G, Cervantes A. Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications. ESMO Open 2019;4:e000470. [PMID: 31231566 DOI: 10.1136/esmoopen-2018-000470] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
20 史 颖. Advances in the Study of Microsatellite Instability and Clinical and Prognosis of Gastric Cancer. ACRPO 2019;08:1-6. [DOI: 10.12677/acrpo.2019.81001] [Reference Citation Analysis]
21 Vrána D, Matzenauer M, Neoral Č, Aujeský R, Vrba R, Melichar B, Rušarová N, Bartoušková M, Jankowski J. From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer. Int J Mol Sci 2018;20:E13. [PMID: 30577521 DOI: 10.3390/ijms20010013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 12.2] [Reference Citation Analysis]
22 Jin S, Xu B, Yu L, Fu Y, Wu H, Fan X, Wei J, Liu B. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy. Oncotarget. 2017;8:38850-38862. [PMID: 28418918 DOI: 10.18632/oncotarget.16407] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
23 Yuza K, Nagahashi M, Watanabe S, Takabe K, Wakai T. Hypermutation and microsatellite instability in gastrointestinal cancers. Oncotarget 2017;8:112103-15. [PMID: 29340115 DOI: 10.18632/oncotarget.22783] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
24 Polom K, Marano L, Marrelli D, De Luca R, Roviello G, Savelli V, Tan P, Roviello F. Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.Br J Surg. 2018;105:159-167. [PMID: 29091259 DOI: 10.1002/bjs.10663] [Cited by in Crossref: 114] [Cited by in F6Publishing: 131] [Article Influence: 19.0] [Reference Citation Analysis]
25 Kim KJ, Lee TH, Kim JH, Cho NY, Kim WH, Kang GH. Deletion in HSP110 T17: correlation with wild-type HSP110 expression and prognostic significance in microsatellite-unstable advanced gastric cancers. Hum Pathol 2017;67:109-18. [PMID: 28811251 DOI: 10.1016/j.humpath.2017.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Mathiak M, Warneke VS, Behrens HM, Haag J, Böger C, Krüger S, Röcken C. Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization.Appl Immunohistochem Mol Morphol. 2017;25:12-24. [PMID: 26371427 DOI: 10.1097/PAI.0000000000000264] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 11.3] [Reference Citation Analysis]
27 Kim JG, Shin S, Park J. Comparison between mononucleotide and dinucleotide marker panels in gastric cancer with loss of hMLH1 or hMSH2 expression. Int J Biol Markers 2017;32:e352-6. [PMID: 28525661 DOI: 10.5301/ijbm.5000266] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
28 Ahn S, Lee SJ, Kim Y, Kim A, Shin N, Choi KU, Lee CH, Huh GY, Kim KM, Setia N, Lauwers GY, Park DY. High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications. Am J Surg Pathol. 2017;41:106-115. [PMID: 27819872 DOI: 10.1097/pas.0000000000000756] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 10.2] [Reference Citation Analysis]
29 Halpern N, Goldberg Y, Kadouri L, Duvdevani M, Hamburger T, Peretz T, Hubert A. Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis. Onco Targets Ther 2017;10:1889-96. [PMID: 28408840 DOI: 10.2147/OTT.S126905] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
30 Panarese I, De Vita F, Ronchi A, Romano M, Alfano R, Di Martino N, Zito Marino F, Ferraraccio F, Franco R. Predictive biomarkers along gastric cancer pathogenetic pathways. Expert Rev Anticancer Ther 2017;17:417-25. [PMID: 28277834 DOI: 10.1080/14737140.2017.1301207] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
31 Goode EF, Smyth EC. Immunotherapy for Gastroesophageal Cancer. J Clin Med. 2016;5. [PMID: 27669318 DOI: 10.3390/jcm5100084] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
32 Lee V, Murphy A, Le DT, Diaz LA Jr. Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade. Oncologist 2016;21:1200-11. [PMID: 27412392 DOI: 10.1634/theoncologist.2016-0046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Lee V, Murphy A, Le DT, Diaz LA Jr. Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade. Oncologist. 2016;21:1200-1211. [PMID: 27412392 DOI: 10.1634/theoncologist.2016-0046] [Cited by in Crossref: 149] [Cited by in F6Publishing: 167] [Article Influence: 21.3] [Reference Citation Analysis]
34 Polom K, Marrelli D, Pascale V, Roviello G, Voglino C, Rho H, Vindigni C, Marini M, Macchiarelli R, Roviello F. High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability. J Cancer Res Clin Oncol 2016;142:1817-24. [DOI: 10.1007/s00432-016-2181-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Cravo M, Fidalgo C, Garrido R, Rodrigues T, Luz G, Palmela C, Santos M, Lopes F, Maio R. Towards curative therapy in gastric cancer: Faraway, so close!. World J Gastroenterol 2015; 21(41): 11609-11620 [PMID: 26556990 DOI: 10.3748/wjg.v21.i41.11609] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
36 Marrelli D, Polom K, Pascale V, Vindigni C, Piagnerelli R, De Franco L, Ferrara F, Roviello G, Garosi L, Petrioli R, Roviello F. Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer. Ann Surg Oncol. 2016;23:943-950. [PMID: 26530444 DOI: 10.1245/s10434-015-4931-3] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 9.3] [Reference Citation Analysis]
37 Richman S. Deficient mismatch repair: Read all about it (Review). Int J Oncol 2015;47:1189-202. [PMID: 26315971 DOI: 10.3892/ijo.2015.3119] [Cited by in Crossref: 117] [Cited by in F6Publishing: 124] [Article Influence: 14.6] [Reference Citation Analysis]
38 Sunakawa Y, Lenz HJ. Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network. Curr Treat Options Oncol. 2015;16:17. [PMID: 25813036 DOI: 10.1007/s11864-015-0331-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
39 Inada R, Sekine S, Taniguchi H, Tsuda H, Katai H, Fujiwara T, Kushima R. ARID1A expression in gastric adenocarcinoma: Clinicopathological significance and correlation with DNA mismatch repair status. World J Gastroenterol 2015; 21(7): 2159-2168 [PMID: 25717252 DOI: 10.3748/wjg.v21.i7.2159] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
40 Zhu L, Li Z, Wang Y, Zhang C, Liu Y, Qu X. Microsatellite instability and survival in gastric cancer: A systematic review and meta-analysis. Mol Clin Oncol. 2015;3:699-705. [PMID: 26137290 DOI: 10.3892/mco.2015.506] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
41 Choi J, Nam SK, Park DJ, Kim HW, Kim H, Kim WH, Lee HS. Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma. APMIS 2015;123:215-22. [DOI: 10.1111/apm.12345] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
42 Velho S, Fernandes MS, Leite M, Figueiredo C, Seruca R. Causes and consequences of microsatellite instability in gastric carcinogenesis. World J Gastroenterol 2014; 20(44): 16433-16442 [PMID: 25469011 DOI: 10.3748/wjg.v20.i44.16433] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
43 Lee J, Kim D. Microsatellite Instability of Nuclear and Mitochondrial DNAs in Gastric Carcinogenesis. Asian Pacific Journal of Cancer Prevention 2014;15:8027-8034. [DOI: 10.7314/apjcp.2014.15.19.8027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Kim HK, Green JE. Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents. Pharmacogenomics 2014;15:375-84. [PMID: 24533716 DOI: 10.2217/pgs.13.250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
45 Penon D, Cito L, Giordano A. Novel findings about management of gastric cancer: A summary from 10th IGCC. World J Gastroenterol 2014; 20(27): 8986-8992 [PMID: 25083072 DOI: 10.3748/wjg.v20.i27.8986] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
46 Williams AS, Huang WY. The analysis of microsatellite instability in extracolonic gastrointestinal malignancy. Pathology 2013;45:540-52. [PMID: 24018804 DOI: 10.1097/PAT.0b013e3283653307] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
47 Choi YY, Bae JM, An JY, Kwon IG, Cho I, Shin HB, Eiji T, Aburahmah M, Kim HI, Cheong JH. Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. J Surg Oncol. 2014;110:129-135. [PMID: 24737677 DOI: 10.1002/jso.23618] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 9.0] [Reference Citation Analysis]
48 Kim K, Lee KS, Cho HJ, Kim YH, Yang HK, Kim WH, Kang GH. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Human Pathology 2014;45:285-93. [DOI: 10.1016/j.humpath.2013.09.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 8.7] [Reference Citation Analysis]
49 Kim JW, Im S, Kim MA, Cho HJ, Lee DW, Lee K, Kim T, Han S, Oh D, Lee H, Kim T, Yang H, Kim WH, Bang Y. Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker: The prognostic value of ATM and MSI in gastric cancer. Int J Cancer 2014;134:72-80. [DOI: 10.1002/ijc.28245] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
50 Lordick F, Röcken C. The identification of predictive factors for perioperative chemotherapy in esophago-gastric cancer. Annals of Oncology 2013;24:1135-8. [DOI: 10.1093/annonc/mdt111] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
51 Kim JY, Shin NR, Kim A, Lee HJ, Park WY, Kim JY, Lee CH, Huh GY, Park do Y. Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes. Korean J Pathol. 2013;47:28-35. [PMID: 23483099 DOI: 10.4132/koreanjpathol.2013.47.1.28] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
52 Kim KJ, Lee TH, Cho NY, Yang HK, Kim WH, Kang GH. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation. Hum Pathol. 2013;44:1055-1064. [PMID: 23266441 DOI: 10.1016/j.humpath.2012.09.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
53 Fang WL, Chang SC, Lan YT, Huang KH, Chen JH, Lo SS, Hsieh MC, Li AF, Wu CW, Chiou SH. Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery. World J Surg. 2012;36:2131-2138. [PMID: 22669398 DOI: 10.1007/s00268-012-1652-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 4.9] [Reference Citation Analysis]
54 Nakanishi R, Kitao H, Fujinaka Y, Yamashita N, Iimori M, Tokunaga E, Yamashita N, Morita M, Kakeji Y, Maehara Y. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer. Ann Surg Oncol. 2012;19:3627-3635. [PMID: 22526901 DOI: 10.1245/s10434-012-2349-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
55 Oki E, Hisamatsu Y, Ando K, Saeki H, Kakeji Y, Maehara Y. Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers. J Gastroenterol 2012;47:351-8. [PMID: 22402775 DOI: 10.1007/s00535-012-0565-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
56 Ottini L, Falchetti M, Nesi G. Gene Signatures in Gastric Cancer. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures 2012. [DOI: 10.1007/978-1-61779-358-5_7] [Reference Citation Analysis]
57 An JY, Kim H, Cheong JH, Hyung WJ, Kim H, Noh SH. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. Int J Cancer. 2012;131:505-511. [PMID: 21898388 DOI: 10.1002/ijc.26399] [Cited by in Crossref: 91] [Cited by in F6Publishing: 101] [Article Influence: 7.6] [Reference Citation Analysis]
58 Baumann JL, Li M, Poulsen A, Chadwick NS, Cai Q, Chung CH, Shyr Y, Olsen JH, Zheng W, Slebos RJ. Analysis of microsatellite mutations in buccal cells from a case-control study for lung cancer. Cancer Epidemiol 2012;36:e33-9. [PMID: 22056752 DOI: 10.1016/j.canep.2011.06.003] [Reference Citation Analysis]
59 Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M, Glynne-Jones R. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol. 2011;22 Suppl 5:v1-v9. [PMID: 21633049 DOI: 10.1093/annonc/mdr284] [Cited by in Crossref: 91] [Cited by in F6Publishing: 99] [Article Influence: 7.6] [Reference Citation Analysis]
60 Kim H, An JY, Noh SH, Shin SK, Lee YC, Kim H. High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. J Gastroenterol Hepatol 2011;26:585-92. [PMID: 21332554 DOI: 10.1111/j.1440-1746.2010.06487.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]